Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marsh & Mclennan Companies (MRSH) Change in Acquisitions & Divestments (2021 - 2025)

Marsh & Mclennan Companies (MRSH) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 89.47% year-over-year to $4.0 million, compared with a TTM value of $100.0 million through Dec 2025, up 81.82%, and an annual FY2025 reading of $100.0 million, up 81.82% over the prior year.
  • Change in Acquisitions & Divestments was $4.0 million for Q4 2025 at Marsh & Mclennan Companies, down from $12.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $84.0 million in Q1 2025 and bottomed at $2.0 million in Q4 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $21.9 million, with a median of $11.0 million recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments plummeted 97.47% in 2023, then soared 2000.0% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $11.0 million in 2021, then plummeted by 81.82% to $2.0 million in 2022, then skyrocketed by 900.0% to $20.0 million in 2023, then soared by 90.0% to $38.0 million in 2024, then tumbled by 89.47% to $4.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for MRSH at $4.0 million in Q4 2025, $12.0 million in Q3 2025, and $84.0 million in Q1 2025.